Prostate Cancer Diagnosis
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
9
NCT03991130
High Dose IL-2 in Combination With Anti-PD-1 to Overcome Anti-PD-1 Resistance in Metastatic Melanoma and Renal Cell Carcinoma
Phase: Phase 2
Role: Lead Sponsor
Start: May 23, 2019
Completion: Jan 1, 2025
NCT03991741
Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid Tumors
Phase: Phase 1
Start: Oct 7, 2020
Completion: Jan 26, 2023
Loading map...